These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7714802)
1. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues. Walsh DA; Mapp PI; Polak JM; Blake DR J Pharmacol Exp Ther; 1995 Apr; 273(1):461-9. PubMed ID: 7714802 [TBL] [Abstract][Full Text] [Related]
2. Binding sites for alpha-trinositol (inositol 1,2,6-trisphosphate) in porcine tissues; comparison with Ins(1,4,5)P3 and Ins(1,3,4,5)P4-binding sites. Stricker R; Westerberg E; Reiser G Br J Pharmacol; 1996 Mar; 117(5):919-25. PubMed ID: 8851511 [TBL] [Abstract][Full Text] [Related]
3. Characterization of specific binding sites for alpha-trinositol (D-myo-inositol 1,2,6-trisphosphate) in rat tissues. Yoo H; Fallgren B; Lindahl A; Wahlestedt C Eur J Pharmacol; 1994 Jun; 268(1):55-63. PubMed ID: 7925612 [TBL] [Abstract][Full Text] [Related]
4. Photoaffinity analogue for the anti-inflammatory drug alpha-trinositol: synthesis and identification of putative molecular targets. Chaudhary A; Prestwich GD Bioconjug Chem; 1997; 8(5):680-5. PubMed ID: 9327131 [TBL] [Abstract][Full Text] [Related]
5. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors. Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354 [TBL] [Abstract][Full Text] [Related]
6. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission. Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147 [TBL] [Abstract][Full Text] [Related]
7. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors. Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed. Ralevic V; Edvinsson L; Burnstock G Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403 [TBL] [Abstract][Full Text] [Related]
9. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. Bell D; Millar BC; McDermott BJ Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811 [TBL] [Abstract][Full Text] [Related]
10. Characterization of inositol 1,4,5-trisphosphate-stimulated calcium release from rat cerebellar microsomal fractions. Comparison with [3H]inositol 1,4,5-trisphosphate binding. Stauderman KA; Harris GD; Lovenberg W Biochem J; 1988 Oct; 255(2):677-83. PubMed ID: 3264497 [TBL] [Abstract][Full Text] [Related]
11. Inositol-1,3,4,5-tetrakisphosphate binding sites in control and ras-transformed NIH/3T3 fibroblasts. Taketo M; Yokoyama S; Fukuda M; Mikoshiba K; Higashida H Biochem Biophys Res Commun; 1997 Oct; 239(1):349-52. PubMed ID: 9345323 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y receptor in cultured vascular smooth muscle cells: ligand binding and increase in cytosolic free Ca2+. Mihara S; Shigeri Y; Fujimoto M Biochem Int; 1990 Oct; 22(2):205-12. PubMed ID: 2090091 [TBL] [Abstract][Full Text] [Related]
13. Determination of specificity of a high-affinity inositol 1,3,4,5-tetrakisphosphate binding site at a 42 kDa receptor protein, p42IP4: comparison of affinities of all inositoltris-,-tetrakis-, and -pentakisphosphate regioisomers. Stricker R; Chang YT; Chung SK; Reiser G Biochem Biophys Res Commun; 1996 Nov; 228(2):596-604. PubMed ID: 8920956 [TBL] [Abstract][Full Text] [Related]
14. Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Challiss RA; Willcocks AL; Mulloy B; Potter BV; Nahorski SR Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):861-7. PubMed ID: 2012613 [TBL] [Abstract][Full Text] [Related]
15. Inositol hexakisphosphate binding sites in rat heart and brain. Rowley KG; Gundlach AL; Cincotta M; Louis WJ Br J Pharmacol; 1996 Aug; 118(7):1615-20. PubMed ID: 8842422 [TBL] [Abstract][Full Text] [Related]
16. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling? Bell D; McDermott BJ Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464 [TBL] [Abstract][Full Text] [Related]
17. Identification of a specific Ins(1,3,4,5)P4-binding protein as a member of the GAP1 family. Cullen PJ; Hsuan JJ; Truong O; Letcher AJ; Jackson TR; Dawson AP; Irvine RF Nature; 1995 Aug; 376(6540):527-30. PubMed ID: 7637787 [TBL] [Abstract][Full Text] [Related]
18. beta-Amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes. Cowburn RF; Wiehager B; Sundström E Neurosci Lett; 1995 May; 191(1-2):31-4. PubMed ID: 7659284 [TBL] [Abstract][Full Text] [Related]
19. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat. Sun XY; Edvinsson L; Hedner T J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Sun X; Edvinsson L; Hedner T J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]